Corona medicine for only 35 and 49 rupees! These two companies brought Favipiravir to the Indian market

Corona medicine for only 35 and 49 rupees! These two companies brought Favipiravir to the Indian market

It will work for patients with mild or moderate symptoms of the corona virus.

India's Sun Pharmaceuticals Industries Ltd said on Tuesday that the company would soon start selling its own favipiravir-rich drugs in the country's market. This drug will be used in the treatment of corona. On Wednesday, another pharmaceutical company, Lupine, said it was also launching Favipiravi tablets They have brought this drug to the market for the treatment of low and medium corona sufferers

Covid treatment brings Sun Pharma to market Flugard 6 Flugard (200 mg of Favipiravi): Available in the Indian market at Rs 35 per tablet. This will work in mild or moderate symptoms of the corona virus. The drug was originally made by a Japanese company for influenza. In addition, Lavin's Favipiravi tablets cost Rs 49.

The number of corona cases in the country is increasing day by day In the last few days, the number of victims in India is more than 50,000 Which is a reason to worry enough In this case, Favipiravi's drug has recently been cleared by the Drug Controller General of India (DCGI).

Covid-19 treatment is still officially approved by the central government for the antiviral drugs rich in Favipiravi and Remedaciv. However, Favipiravir is one such oral-oral antiviral that has been approved for the treatment of only moderate symptoms of Covid-19, according to Sun Pharma.

On the other hand, Lupine's Covihult 200 mg tablet has been introduced in the market There are 10 tablets in one page The price is only 49 rupees